Mequon company may be on the verge of CURING MS

Multiple sclerosis is a debilitating, often deadly disease that attacks the body's central nervous system. It can devastate a victim's brain, spinal cord, optic nerves and vision.

The disease is unpredictable. While treatments and medication currently on the market can help slow down the attacks, there is no cure.

Yet.

But the cure for MS just might be sitting right in southeastern Wisconsin's backyard.

Endece LLC, a Mequon-based drug discovery company, recently formed Endece Neural, a subsidiary company focused on neurological drug development. More specifically, Endece Neural is pursing the development of a drug that could help repair and even reverse the damage caused by MS.

Endece's work is getting some attention in the world of MS research.

"We're very excited about the Endece compounds," said Jay Tung, president of drug discovery at the Myelin Repair Foundation in San Francisco.

Endece hopes to collect enough data so the U.S. Food and Drug Administration will accelerate clinical testing enough to have the drug on the market in five to seven years.

"We've already proven that our compound and even our backup compounds work in in vitro (in Petri dish) environments," said James Yarger, chief executive officer of Endece.

The central nervous system is made up of the brain, the spinal cord and the optic nerves in a body.

See the rest here:
Mequon company may be on the verge of CURING MS